CMS Rolls Out Value-Based Gene Therapy Model for Sickle Cell Disease



(MedPage Today) — The Centers for Medicare & Medicaid Services (CMS) announced Tuesday that 33 states, as well as the District of Columbia and Puerto Rico, have agreed to participate in the Cell and Gene Therapy (CGT) Access Model, which is…



Source link : https://www.medpagetoday.com/hematologyoncology/othercancers/116528

Author :

Publish date : 2025-07-16 20:32:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version